Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 10X Genomics Inc (TXG) vs United Airlines Holdings Inc (UAL) Price & Performance

10X Genomics IncTrade
United Airlines Holdings IncTrade

Price performance (Past 24H)

Key statistics

10X Genomics Inc vs United Airlines Holdings Inc — how do they compare? 10X Genomics Inc trades at $67.8 (market cap $8.55B), while United Airlines Holdings Inc trades at $107.36 (market cap $35.13B). The key difference: United Airlines Holdings Inc is far larger — about 4.1× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals.

TXGUAL
Market Cap
$8.55B$35.13B
Sector
HealthIndustrials
52-Week High
$67.29$136.11
52-Week Low
$11.34$85.21
Enterprise Value
$8.08B$52.16B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

10X Genomics Inc

TXG trades at $65.60, up 4.71% today, with strong technical momentum showing bullish moving averages and key support at $63. Fundamentally, the company demonstrates improving trends with Q2 2026 earnings beating estimates and revenue growth guidance raised, though profitability remains negative with a -12.18% net margin. Recent patent victory against Parse Biosciences strengthens competitive positioning.

The outlook remains cautiously optimistic with analyst consensus at 45% buy ratings and $50.78 price target. Key opportunities include Atera platform adoption and consumables growth, while risks center on valuation premiums and ongoing profitability challenges. The stock trades near resistance at $67 with institutional interest showing mixed signals.

United Airlines Holdings Inc

United Airlines (UAL) trades at $108.24, down 2.82% today, with a bearish technical signal but strong fundamentals including a P/E of 10.13 and net income margin of 5.56%. The company has beaten EPS estimates for three consecutive quarters and announced its largest international expansion, adding 10 new routes for 2027. Cash flow trends show volatility, with 2025 net cash flow negative at -$2.86 billion but projected to turn positive in 2026.

The outlook is mixed: analyst consensus is strongly bullish with a $168.96 price target, but high jet fuel costs and geopolitical risks pose headwinds. Earnings growth and international expansion are key catalysts, while debt levels and operational efficiency remain areas to watch for sustained shareholder value.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG

About United Airlines Holdings Inc

United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.

Read more on UAL